Decursin and PDBu

Two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells

Hyeon H. Kim, Kyung Seop Ahn, Hogyu Han, Se Young Choung, Sang-Yun Choi, Ik Hwan Kim

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Protein kinase C (PKC) plays an important role in the proliferation and differentiation of various cell types including normal and leukemic hematopoietic cells. Phorbol 12,13-dibutyrate (PDBu) induces the megakaryocytic differentiation of K562 human erythroleukemia cells through PKC activation. Decursin, a pyranocoumarin from Angelica gigas, exhibits the cytotoxic effects on various human cancer cell lines and in vitro PKC activation. We report here the differences between two PKC activators, tumor-suppressing decursin and tumor-promoting PDBu, in their actions on the megakaryocytic differentiation of K562 cells. First of all, decursin inhibited PDBu-induced bleb formation in K562 cells. Decursin also inhibited the PDBu-induced megakaryocytic differentiation of K562 cells that is characterized by an increase in substrate adhesion, the secretion of granulocyte/macrophage colony stimulating factor (GM-CSF) and interleukin-6 (IL-6), and the surface expression of integrin β3. The binding of PDBu to PKC was competitively inhibited by decursin. Decursin induced the more rapid down-regulation of PKC α and βII isozymes than that induced by PDBu in K562 cells. Unlike PDBu, decursin promoted the translocation of PKC α and βII to the nuclear membrane. Decursin-induced faster down-regulation and nuclear translocation of PKC α and βII were not affected by the presence of PDBu. All these results indicate that decursin and phorbol ester are PKC activators distinctively acting in megakaryocytic differentiation and PKC modulation in K562 leukemia cells.

Original languageEnglish
Pages (from-to)1407-1413
Number of pages7
JournalLeukemia Research
Volume29
Issue number12
DOIs
Publication statusPublished - 2005 Dec 1

Fingerprint

Phorbol 12,13-Dibutyrate
Leukemia, Erythroblastic, Acute
Protein Kinase C
K562 Cells
Pyranocoumarins
Down-Regulation
Angelica
decursin
Neoplasms
Nuclear Envelope
Phorbol Esters
Blister
Granulocyte-Macrophage Colony-Stimulating Factor
Nuclear Proteins
Integrins
Isoenzymes
Cell Differentiation
Interleukin-6
Leukemia

Keywords

  • Decursin
  • Leukemia
  • Phorbol ester
  • PKC

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Decursin and PDBu : Two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells. / Kim, Hyeon H.; Ahn, Kyung Seop; Han, Hogyu; Choung, Se Young; Choi, Sang-Yun; Kim, Ik Hwan.

In: Leukemia Research, Vol. 29, No. 12, 01.12.2005, p. 1407-1413.

Research output: Contribution to journalArticle

@article{06c3be61f02445d7b3c3d82dae26b134,
title = "Decursin and PDBu: Two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells",
abstract = "Protein kinase C (PKC) plays an important role in the proliferation and differentiation of various cell types including normal and leukemic hematopoietic cells. Phorbol 12,13-dibutyrate (PDBu) induces the megakaryocytic differentiation of K562 human erythroleukemia cells through PKC activation. Decursin, a pyranocoumarin from Angelica gigas, exhibits the cytotoxic effects on various human cancer cell lines and in vitro PKC activation. We report here the differences between two PKC activators, tumor-suppressing decursin and tumor-promoting PDBu, in their actions on the megakaryocytic differentiation of K562 cells. First of all, decursin inhibited PDBu-induced bleb formation in K562 cells. Decursin also inhibited the PDBu-induced megakaryocytic differentiation of K562 cells that is characterized by an increase in substrate adhesion, the secretion of granulocyte/macrophage colony stimulating factor (GM-CSF) and interleukin-6 (IL-6), and the surface expression of integrin β3. The binding of PDBu to PKC was competitively inhibited by decursin. Decursin induced the more rapid down-regulation of PKC α and βII isozymes than that induced by PDBu in K562 cells. Unlike PDBu, decursin promoted the translocation of PKC α and βII to the nuclear membrane. Decursin-induced faster down-regulation and nuclear translocation of PKC α and βII were not affected by the presence of PDBu. All these results indicate that decursin and phorbol ester are PKC activators distinctively acting in megakaryocytic differentiation and PKC modulation in K562 leukemia cells.",
keywords = "Decursin, Leukemia, Phorbol ester, PKC",
author = "Kim, {Hyeon H.} and Ahn, {Kyung Seop} and Hogyu Han and Choung, {Se Young} and Sang-Yun Choi and Kim, {Ik Hwan}",
year = "2005",
month = "12",
day = "1",
doi = "10.1016/j.leukres.2005.05.001",
language = "English",
volume = "29",
pages = "1407--1413",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - Decursin and PDBu

T2 - Two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells

AU - Kim, Hyeon H.

AU - Ahn, Kyung Seop

AU - Han, Hogyu

AU - Choung, Se Young

AU - Choi, Sang-Yun

AU - Kim, Ik Hwan

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Protein kinase C (PKC) plays an important role in the proliferation and differentiation of various cell types including normal and leukemic hematopoietic cells. Phorbol 12,13-dibutyrate (PDBu) induces the megakaryocytic differentiation of K562 human erythroleukemia cells through PKC activation. Decursin, a pyranocoumarin from Angelica gigas, exhibits the cytotoxic effects on various human cancer cell lines and in vitro PKC activation. We report here the differences between two PKC activators, tumor-suppressing decursin and tumor-promoting PDBu, in their actions on the megakaryocytic differentiation of K562 cells. First of all, decursin inhibited PDBu-induced bleb formation in K562 cells. Decursin also inhibited the PDBu-induced megakaryocytic differentiation of K562 cells that is characterized by an increase in substrate adhesion, the secretion of granulocyte/macrophage colony stimulating factor (GM-CSF) and interleukin-6 (IL-6), and the surface expression of integrin β3. The binding of PDBu to PKC was competitively inhibited by decursin. Decursin induced the more rapid down-regulation of PKC α and βII isozymes than that induced by PDBu in K562 cells. Unlike PDBu, decursin promoted the translocation of PKC α and βII to the nuclear membrane. Decursin-induced faster down-regulation and nuclear translocation of PKC α and βII were not affected by the presence of PDBu. All these results indicate that decursin and phorbol ester are PKC activators distinctively acting in megakaryocytic differentiation and PKC modulation in K562 leukemia cells.

AB - Protein kinase C (PKC) plays an important role in the proliferation and differentiation of various cell types including normal and leukemic hematopoietic cells. Phorbol 12,13-dibutyrate (PDBu) induces the megakaryocytic differentiation of K562 human erythroleukemia cells through PKC activation. Decursin, a pyranocoumarin from Angelica gigas, exhibits the cytotoxic effects on various human cancer cell lines and in vitro PKC activation. We report here the differences between two PKC activators, tumor-suppressing decursin and tumor-promoting PDBu, in their actions on the megakaryocytic differentiation of K562 cells. First of all, decursin inhibited PDBu-induced bleb formation in K562 cells. Decursin also inhibited the PDBu-induced megakaryocytic differentiation of K562 cells that is characterized by an increase in substrate adhesion, the secretion of granulocyte/macrophage colony stimulating factor (GM-CSF) and interleukin-6 (IL-6), and the surface expression of integrin β3. The binding of PDBu to PKC was competitively inhibited by decursin. Decursin induced the more rapid down-regulation of PKC α and βII isozymes than that induced by PDBu in K562 cells. Unlike PDBu, decursin promoted the translocation of PKC α and βII to the nuclear membrane. Decursin-induced faster down-regulation and nuclear translocation of PKC α and βII were not affected by the presence of PDBu. All these results indicate that decursin and phorbol ester are PKC activators distinctively acting in megakaryocytic differentiation and PKC modulation in K562 leukemia cells.

KW - Decursin

KW - Leukemia

KW - Phorbol ester

KW - PKC

UR - http://www.scopus.com/inward/record.url?scp=27644490806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644490806&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2005.05.001

DO - 10.1016/j.leukres.2005.05.001

M3 - Article

VL - 29

SP - 1407

EP - 1413

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 12

ER -